AI assistant
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2013
Feb 28, 2013
30583_dirs_2013-02-28_7f3c4a72-87a3-4dce-ab7f-79d5097e3380.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2013-02-27
Reporting Person: Davis George Eric (SVP, General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-02-27 | Common Stock | M | 3417 | $17.54 | Acquired | 49617 | Direct |
| 2013-02-27 | Common Stock | M | 4583 | $14.39 | Acquired | 54200 | Direct |
| 2013-02-27 | Common Stock | S | 8000 | $56.8982 | Disposed | 46200 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-02-27 | Stock Option (right to buy) Common Stock | $17.54 | M | 3417 | Disposed | 2016-11-19 | Common Stock (3417) | Direct |
| 2013-02-27 | Stock Option (right to buy) Common Stock | $14.39 | M | 4583 | Disposed | 2019-05-11 | Common Stock (4583) | Direct |
Footnotes
F1: The price in Column 4 is a weighted average price. The prices actually received ranged from $56.80 to $57.04. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F2: Original option grant vests 6/48ths on May 20, 2007 and 1/48th on the 20th day of every month thereafter.
F3: Original option grant vests 6/48ths on November 12, 2009 and 1/48th on the 12th day of every month thereafter.